Global Genome Editing Market - Size, Trends, Competitive Analysis, Market Share and Forecasts (2019-2026)

The Global Genome Editing market was valued at USD xx million in 2018 and is forecasted to reach USD xx million by 2025, with a CAGR of xx% during the forecast period 2019-2026.

Genome editing is a scientific way of modifying DNA of many organisms such as plants, bacteria, and animals. By making changes in DNA it leads to change in physical traits, like eye color, and disease risk. Scientists use different technologies to carry out to remove, add, or replace the DNA where it was edited.

The market growth is driven by several factors such as growing government initiatives in genome editing field and raising awareness of the genomics. However, a high cost of genomic equipment is restraining the market.

Product Insights:

The Global Genome Editing market is segmented by Technology into CRISPR/Cas, TALEN, Zinc Finger Nuclease (ZFN), and Others. The CRISPR/Cas segment accounted for the largest share of the global genome editing market as in 2017 due to its ability to multiply It has the property of mutating multiple genes at a single time in parallel to target multiple sites simultaneously in the same cell.

Advancement in the development of genome engineering technology such as zinc finger nuclease, TALEN, and CRISPR/Cas9 system is contributing in a study of the genomes of various organisms at the functional level easily and accurately.

Application Insights:

By applications, the market is segmented into Genetic Engineering (Plant, Animal), Cell Line Engineering, Curing genetic diseases, Drug Discovery and Development, and Others. The cell line engineering segment is accounted for the largest market share of global genome editing market due to several factors such as raising awareness related to stem cell therapies globally, growing stem cell research industry, and raising funds from governments and private organizations.

End-User Insights:

Further, based on end-user, the market is segmented into Government & Academic Research Institutes, Biotech & Pharmaceutical Companies, and Contract Research Organizations. The biotech & pharmaceutical companies segment is accounted for the largest market share of global genome editing market due to growing research activities for increasing infectious diseases and cancer cases globally.

Regional Insights:

Geographically, the market is segmented into North America, South America, Europe, Asia-Pacific, and RoW. North America dominates the global genome editing market due to several factors such as the development of gene therapy in the US, increasing cases of infectious diseases and cancer, and growing usage of genetically modified (GM) crops.

The major players of global Genome Editing market include Alere Inc, Genscript USA Inc., Thermo Fisher Scientific Inc., Horizon Discovery Group PLC, Merck KGaA, Origene Technologies Inc., Sangamo Biosciences Inc., Transposagen Biopharmaceuticals Inc., Integrated DNA Technologies Inc., and Synbio Technologies.

The report covers the factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.

Why purchase the report?

Visualize the composition of the Global Genome Editing market across each indication, in terms of type and applications, highlighting the key commercial assets and players.

Identify commercial opportunities in Global Genome Editing by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of the Global Genome Editing market - level 4/5 segmentation

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study

Product mapping in excel for the key Global Genome Editing products of all major market players

Table of Contents

Chapter 1. Methodology and Scope

• 1.1 Research methodology
• 1.2 Scope of the Report

Chapter 2 Global Genome Editing Market -Trends

• 2.1 Key Trends & Developments

Chapter 3 Global Genome Editing Market - Industry Analysis

• 3.1 Industry Impact Factors (Drivers & Restraints)
• 3.2 Competitive Intensity- Porter 5 Forces
• 3.3 Regulatory Analysis

Chapter 4 Global Genome Editing Market- Product Analysis

• 4.1. Genome Editing Market - By Technology
• 4.1.1 Antisense
• 4.1.2 CRISPR/Cas
• 4.1.3 TALEN
• 4.1.4 Zinc Finger Nuclease (ZFN)
• 4.1.5 Others
• 4.2. Genome Editing Market - By Applications
• 4.2.1 Genetic Engineering
• 4.2.1.1 Plant Genetic Engineering
• 4.2.1.2 Animal Genetic Engineering
• 4.2.2 Cell Line Engineering
• 4.2.3 Curing genetic diseases
• 4.2.4 Drug Discovery and Development
• 4.2.6 Others
• 4.3 Genome Editing Market - By End-User
• 4.3.1 Contract Research Organizations
• 4.3.2 Biotech & Pharmaceutical Companies
• 4.3.3 Government & Academic Research Institutes

Chapter 5 Global Genome Editing Market- Geographical Analysis

• 5.1. Asia Pacific
• 5.1.1. China
• 5.1.2. Japan
• 5.1.3. India
• 5.1.4. Australia
• 5.1.5. Rest of Asia Pacific
• 5.2. Europe
• 5.2.1. Germany
• 5.2.2. France
• 5.2.3. The UK
• 5.2.4. Italy
• 5.2.5. Spain
• 5.2.6. Rest of Europe
• 5.3. North America
• 5.3.1. The USA
• 5.3.2. Canada
• 5.3.3. Mexico
• 5.4. South America
• 5.4.1. Brazil
• 5.4.2. Argentina
• 5.4.3. Rest of South America
• 5.5. RoW

Chapter 6 Global Genome Editing Market - Competitive Landscape

• 6.1 Market Share Analysis
• 6.2 Key Strategies
• 6.3 Product Benchmarking

Chapter 7 Global Genome Editing Market - Company Profiles

• 7.1 Alere, Inc
• 7.2 Genscript USA Inc.
• 7.3 Thermo Fisher Scientific, Inc.
• 7.4 Horizon Discovery Group PLC
• 7.5 Merck KGaA
• 7.6 Origene Technologies, Inc.
• 7.7 Sangamo Biosciences, Inc.
• 7.8 Transposagen Biopharmaceuticals, Inc.
• 7.9 Integrated DNA Technologies, Inc.
• 7.10 Synbio Technologies

Chapter 8 Global Genome Editing Market - Appendix

• 8.1 Sources
• 8.2 List of Tables
• 8.3 Expert Panel Validation
• 8.4 Disclaimer
• 8.5 Contact Us